Michele Schulz, MD
Orthopaedic Surgery · Fresno, CANPI 1891778775
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,069 of the $1,547 with a category attached, or 69.1%. 13 manufacturers reported payments, led by Arthrex at 41.1% of the total. Reporting peaked in 2024 at $813 and has fallen 87.5% since, to $101 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in CA, where the typical reported total is $2,444.
Across 34 payments — averaging $45.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$636
- Johnson & Johnson$264
- Heron Therapeutics, Inc.$164
- Medtronic$138
- Cornerstone Medical Associates, Inc.$109
- Davol Inc.$48
- plus $188 from 7 others
Across 4 payments — averaging $12,500 each. An ownership or investment interest held by the physician or an immediate family member.
- Lazurite Inc.$50K
What the payments were for
- Travel & lodging$47731%
- Food & beverage$1,06969%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 11 | $636 |
| Johnson & Johnson(2 entities) | 6 | $264 |
| Heron Therapeutics, Inc. | 3 | $164 |
| Medtronic | 1 | $138 |
| Cornerstone Medical Associates, Inc. | 3 | $109 |
| Davol Inc. | 1 | $48 |
| Smith+Nephew | 2 | $37 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $34 |
| Medical Device Business Services, Inc. | 2 | $32 |
| Pacira Therapeutics, Inc. | 1 | $30 |
| Amgen | 1 | $20 |
| Heraeus Medical, LLC. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUAMANTYS$138
- Zynrelef$122
How this compares
$1,547 in reported general payments places this provider in the 40th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 25 | $634 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $264 |
| Meloxicam | 47 | $141 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Fresno
- Connor TellesFresno$1M
- Julia LeeFresno$458K
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.